Related Experiment Video

Updated: Oct 16, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus infection: review and implications for the orthopedic surgeon

B J McGrory1, A E Kilby

  • 1Maine Joint Replacement Institute, Orthopaedic Associates of Portland, USA.

American Journal of Orthopedics (Belle Mead, N.J.)
|April 28, 2000
PubMed

Insights

Hepatitis C virus (HCV) affects 1-2% of the US population, with higher rates in orthopedic surgery patients. Orthopedic surgeons must understand HCV for patient safety and surgical planning.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Orthopedic Surgery

Background:

  • Hepatitis C virus (HCV) is a significant global health concern, identified in 1989.
  • An estimated 1%-2% of the United States population is infected with HCV.
  • The incidence of HCV infection can be as high as 5% in patients undergoing orthopedic surgery.

Purpose of the Study:

  • To inform orthopedic surgeons about Hepatitis C virus (HCV) infection.
  • To highlight the risks of blood-borne diseases for surgical teams.
  • To provide guidance on managing HCV-positive patients in the context of orthopedic surgery.

Main Methods:

  • Review of the natural history of HCV infection.
  • Analysis of HCV transmission routes, particularly in surgical settings.
  • Evaluation of current diagnostic and treatment strategies for HCV.

Main Results:

  • Orthopedic surgeons may be the first to diagnose HCV in patients donating autologous blood.
  • Awareness of HCV is crucial for operating room team safety.
  • Understanding HCV allows for informed surgical planning and patient counseling.

Conclusions:

  • Orthopedic surgeons play a key role in identifying and managing Hepatitis C virus (HCV).
  • Knowledge of HCV natural history, transmission, and treatment is essential for safe surgical practice.
  • Proactive management of HCV-positive patients optimizes surgical outcomes and team safety.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...